Maxim Group initiates coverage of Legacy Education and Nasus Pharma at Buy
Maxim Group started coverage of Legacy Education and Nasus Pharma with Buy ratings, with price targets of $16 and $7, per TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Maxim Group initiated coverage of Legacy Education with a Buy rating and a $16 price target. That target implies 61.6% upside from the October 29 close of $9.90.
The firm also started coverage of Nasus Pharma with the same rating and a $7 target. That target implies 119.4% upside from the October 29 close of $3.19. TradingView reports both figures, citing reference data from Benzinga.
why it matters
Fresh broker coverage can draw attention to lesser-known stocks, but such initiations rarely move the broader market. Price targets are an analyst's estimate rather than a promise of gains, and thinly traded shares can react sharply even to modest news.
tags
instruments
sources
- Maxim Group initiates coverage of Legacy Education at Buy, sets price target at $16 — TradingView, 30 October 2026 at 13:32 UTC
- Maxim Group initiates coverage of Nasus Pharma at Buy, sets price target at $7 — TradingView, 30 October 2026 at 13:31 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗